These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 13853881

  • 41. [Relation between zymosan, properdin & tumors. 2. Behavior of properdin level in rats with benzpyrene-induced sarcomas].
    MODICA F, FUMAROLA D.
    Tumori; 1958; 44(6):549-54. PubMed ID: 13635873
    [No Abstract] [Full Text] [Related]

  • 42. [A quantitative method of serum properdin determination with inulin (Preliminary experiences)].
    SCHEIFFARTH F, FRENGER W, RINGELMANN R.
    Klin Wochenschr; 1960 Mar 15; 38():291. PubMed ID: 14442572
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Replacement of magnesium by cobalt and manganese in the interactions of the properdin system with bacteria and with zymosan.
    WARDLAW AC, BLUM L, PILLEMER L.
    J Immunol; 1958 Jul 15; 81(1):43-7. PubMed ID: 13563878
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The properdin system and immunity. IX. Studies on the purification of human properdin.
    TODD EW, PILLEMER L, LEPOW IH.
    J Immunol; 1959 Oct 15; 83():418-27. PubMed ID: 13838615
    [No Abstract] [Full Text] [Related]

  • 48. [On properdin determination in the serum of rats with rapidly growing inoculation tumors].
    KALLENBACH H, THUERIGEN G.
    Z Gesamte Exp Med; 1960 Oct 15; 133():304-9. PubMed ID: 13750946
    [No Abstract] [Full Text] [Related]

  • 49. [STUDIES ON SERUM PROPERDIN IN OBSTETRICS AND GYNECOLOGY].
    INOUE M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1963 Dec 15; 15():1315-25. PubMed ID: 14100049
    [No Abstract] [Full Text] [Related]

  • 50. The properdin system and immunity. X. Characterization of partially purified human properdin.
    LEPOW IH, PILLEMER L, SCHOENBERG MD, TODD EW, WEDGWOOD RJ.
    J Immunol; 1959 Oct 15; 83():428-36. PubMed ID: 14415902
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [On the use of different zymosans for the study of the properdin system].
    CHERNOKHVOSTOVA NV, NIKITINA VD, KHOLCHEV NV.
    Lab Delo; 1963 Feb 15; 9():15-9. PubMed ID: 14020618
    [No Abstract] [Full Text] [Related]

  • 56. [Mouse protection studies with zymosan vaccines and properdin sera. Contribution to unspecified immunity (resistance)].
    ZIMMERMANN G.
    Acta Biol Med Ger; 1962 Feb 15; 9():412-27. PubMed ID: 14003718
    [No Abstract] [Full Text] [Related]

  • 57. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB, Hedrick SW, Ratnoff WD, Novak MA, Smith MC, Steiner C, Todd EW.
    J Immunol; 1980 Jun 15; 124(6):2625-31. PubMed ID: 6900053
    [Abstract] [Full Text] [Related]

  • 58. [The properdin level in neoplasms and in malignant blood diseases].
    DIOMEDE-FRESA V, FUMAROLA A.
    Prog Med (Napoli); 1959 May 31; 15():310-4. PubMed ID: 13816890
    [No Abstract] [Full Text] [Related]

  • 59. [The properdin picture in psoriasis vulgaris. (Preliminary report)].
    POLGAR P, SZABO A.
    Dermatol Wochenschr; 1961 Dec 23; 144():1426-8. PubMed ID: 14487525
    [No Abstract] [Full Text] [Related]

  • 60. [Variations of properdin in cancer patients].
    MARQUES P, DOUSTE-BLAZY L, LLOVERAS J, PUEL J.
    Bull Assoc Fr Etud Cancer; 1960 Dec 23; 47():479-87. PubMed ID: 13767080
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.